Emyria (ASX:EMD) Common Stock: A$50.77 Mil (As of Dec. 2025)


What is Emyria Common Stock?

Emyria ASX:EMD -2.50% Common Stock is A$50.77 Mil as of Dec. 2025. The stock has 1 warning sign investors should review.

Emyria's quarterly common stock increased from Dec. 2024 (A$38.11 Mil) to Jun. 2025 (A$41.89 Mil) and increased from Jun. 2025 (A$41.89 Mil) to Dec. 2025 (A$50.77 Mil).

Emyria's annual common stock increased from Jun. 2023 (A$29.80 Mil) to Jun. 2024 (A$36.26 Mil) and increased from Jun. 2024 (A$36.26 Mil) to Jun. 2025 (A$41.89 Mil).

Emyria Common Stock Historical Data

* Premium members only.

The historical data trend for Emyria's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Emyria Common Stock Chart

Emyria Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Common Stock
Get a 7-Day Free Trial 19.31 24.64 29.80 36.26 41.89

Emyria Semi-Annual Data
Jun19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.34 36.26 38.11 41.89 50.77

Emyria Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of A$50.77 Mil mean?
Emyria (ASX:EMD) has a Common Stock of A$50.77 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Emyria and its competitors.
Is Emyria's Common Stock too high?
Emyria's current Common Stock is A$50.77 Mil.
How does Emyria's Common Stock compare to VEEV and BTSG?
Emyria's Common Stock of A$50.77 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Healthcare Providers & Services company?
A good Common Stock depends on the Healthcare Providers & Services industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Emyria and its competitors. Emyria's current Common Stock is A$50.77 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Emyria stock overvalued right now?
Based on GuruFocus' analysis, Emyria (ASX:EMD) is currently considered Modestly Overvalued. The stock's GF Value™ is A$0.03, compared to a current price of A$0.04 — trading 30% above its estimated fair value. The current Common Stock is A$50.77 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Emyria (ASX:EMD), the current Common Stock is A$50.77 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Emyria Business Description

Other Exchanges Q84:Germany
Address D2, 661 Newcastle Street, PO Box 1442, Leederville, WA, AUS, 6007
Emyria Ltd operates a network of specialist medical clinics and uses purpose-built software and technology to gather clinical data from consenting patients. It operates in one segment of research and development.